FDA Adverse Event Malfunction Summary report: N

COULTER ACT 5DIFF CAP PIERCE

MDR report key: 3933391 · Received July 14, 2014

Report

Report Number
1061932-2014-01656
Event Type
Malfunction
Date Received
July 14, 2014
Date of Event
May 21, 2014
Report Date
June 16, 2014
Manufacturer
BECKMAN COULTER
Product Code
GKZ
PMA / PMN Number
K042173
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
RS
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE FIELD SERVICE ENGINEER (FSE) EVALUATED THE INSTRUMENT AND DISCOVERED SALT BUILDUP ON THE REAR SIDE OF THE FLOWCELL AS A RESULT OF A CRACK IN THE FLOWCELL. THE FSE ORDERED A NEW REPLACEMENT PART TO BE SENT TO THE CUSTOMER TO ADDRESS THE ISSUE. THE CAUSE OF THE DISCREPANT RESULTS IS LIKELY ATTRIBUTED TO THE CRACKED FLOWCELL.

Description of Event or Problem · 1

THE CUSTOMER REPORTED OBTAINING ERRONEOUS DIFFERENTIAL RESULTS FOR APPROXIMATELY TEN (10) PATIENT SAMPLES FROM THE COULTER ACT 5DIFF CAP PIERCE. THE CUSTOMER STATED THAT THE INSTRUMENT GENERATED R FLAGS FOR THE DIFFERENTIAL RESULTS AND SUBOPTIMAL SCATTERGRAMS. R FLAGS ARE GENERATED TO ALERT THE CUSTOMER TO REVIEW THE RESULTS. THE CUSTOMER PROVIDED ONLY FOUR (4) PATIENT SAMPLE RESULTS FOR REVIEW. A REVIEW OF THE PATIENT RESULTS INDICATES THAT THE INITIAL SAMPLE RUNS FOR THE FOUR (4) PATIENTS GENERATED HIGHER LYMPHOCYTE (LY) AND LOWER NEUTROPHIL (NE) RESULTS ALONG WITH INSTRUMENT GENERATED FLAGS WHEN COMPARED TO THE MANUAL DIFFERENTIAL RESULTS WHICH THE CUSTOMER CONSIDERED CORRECT. PATIENT #4 ALSO SHOWED HIGHER MONOCYTE (MO) AND EOSINOPHIL (EOS) RESULTS WHEN COMPARED TO THE MANUAL DIFFERENTIAL RESULTS. THE ERRONEOUS RESULTS WERE NOT REPORTED OUT OF THE LABORATORY AND THERE WAS NO CHANGE OR AFFECT TO PATIENT TREATMENT IN CONNECTION WITH THIS EVENT. QUALITY CONTROL RESULTS PRIOR TO THE EVENT WERE WITHIN SPECIFICATIONS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
409616 COULTER ACT 5DIFF CAP PIERCE COUNTER, DIFFERENTIAL CELL GKZ BECKMAN COULTER NA NA

Patients

Seq Age Sex Outcome Treatment
1